PX
73
-6
MAT
38
-3
NOC
40
-10
XOM
51
3
CVX
38
6
XRX
34
-3
REGN
42
-2
INTC
49
16
DD
61
4
PFG
50
-2
TROW
51
-2
VZ
42
3
TXN
49
-6
MU
32
-6
EFX
41
-2
ACN
70
5
DE
36
-2
MLM
57
-3
AIZ
78
2
LRCX
46
-2
PX
73
-6
MAT
38
-3
NOC
40
-10
XOM
51
3
CVX
38
6
XRX
34
-3
REGN
42
-2
INTC
49
16
DD
61
4
PFG
50
-2
TROW
51
-2
VZ
42
3
TXN
49
-6
MU
32
-6
EFX
41
-2
ACN
70
5
DE
36
-2
MLM
57
-3
AIZ
78
2
LRCX
46
-2
Financhill
Back

OncoCyte Vs. Neurogene Industry Stock Comparison

Sell
50

OCX
OncoCyte

Last Price:
2.90
Seasonality Move:
46.75%
Sell
5

NGNE
Neurogene

Last Price:
39.96
Seasonality Move:
50.43%
Sell
50
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.90. The Score for OCX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 43.58 Sell
Chaikin Money Flow: -1634 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.92 - 3.12) Sell
Bollinger Bands (100): (2.92 - 3.2) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.89 Buy
20-day SMA: 3 Sell
50-day SMA: 3.03 Sell
200-day SMA: 2.95 Sell
8-day EMA: 2.91 Sell
20-day EMA: 2.96 Sell
50-day EMA: 3.01 Sell
200-day EMA: 3.24 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):